CIK 0001676725
- Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474268251
- Phone
- +1 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 117,996 shares at an average $14.31 ($1,688,929)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 3,100 shares at an average $17.97 ($55,717)
- 3/A Insider 3/A
- 4 Open-market sale SVP, Head of Biology sold 7,123 shares at an average $15.19 ($108,188)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP, General Counsel sold 2,205 shares at $8.66 ($19,087)
- 4 Open-market sale SVP, Head of Biology sold 845 shares at an average $9.21 ($7,779)
- 4 Option exercise President and CEO acquired 47,564 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 10 · 197 filings